Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is based in Visakhapatnam, India.
Key Metrics
as of Sep 2026
Market Cap 121 Cr
P/E โ
Div Yield 0.00 %
Book Value โน-75.50
52w High โน82.50
52w Low โน38.30
Face Value โน10.00
Quarterly Results
Rs. Crores ยท hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
6.98
6.81
7.27
4.17
5.48
6.10
11.47
12.86
12.89
11.97
12.98
14.89
10.58
Expenses
6.16
7.67
6.97
6.97
7.57
11.51
16.18
15.58
15.08
15.09
15.07
15.79
13.20
Operating Profit
0.82
-0.86
0.30
-2.80
-2.09
-5.41
-4.71
-2.72
-2.19
-3.12
-2.09
-0.90
-2.62
OPM %
11.75
-12.63
4.13
-67.15
-38.14
-88.69
-41.06
-21.15
-16.99
-26.07
-16.10
-6.04
-24.76
Other Income
0.16
2.00
0.00
0.01
0.01
0.34
0.25
0.09
0.03
0.21
0.03
0.17
0.04
Depreciation
1.59
1.57
1.63
1.62
1.60
1.57
1.72
1.71
1.69
1.67
1.73
1.71
1.65
Interest
1.88
1.91
1.79
1.73
1.65
1.61
1.56
1.42
1.32
1.27
1.19
1.13
1.10
Profit before tax
-2.49
-2.34
-3.12
-6.14
-5.33
-8.25
-7.74
-5.76
-5.17
-5.85
-4.98
-3.57
-5.33
Tax %
0.00
0.00
0.00
0.00
0.00
0.24
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-2.48
-2.34
-3.13
-6.14
-5.32
-8.27
-7.74
-5.76
-5.17
-5.85
-4.98
-3.57
-5.33
EPS in Rs
-1.15
-1.09
-1.45
-2.85
-2.47
-3.84
-3.59
-2.67
-2.40
-2.71
-2.31
-1.66
-2.47
Profit & Loss
Annual ยท Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
24.00 43.00 50.00 52.00 60.00 54.00 33.00 48.00 34.00 3.00 1.00 0.00
Expenses
29.00 58.00 59.00 68.00 94.00 71.00 52.00 58.00 41.00 11.00 14.00 5.00
Operating Profit
-5.00 -15.00 -9.00 -16.00 -34.00 -18.00 -19.00 -10.00 -8.00 -8.00 -12.00 -5.00
OPM %
-23.00 -35.00 -17.00 -30.00 -57.00 -33.00 -56.00 -20.00 -22.00 -248.00 -1,088.00 โ
Other Income
2.00 1.00 0.00 1.00 1.00 1.00 0.00 0.00 -1.00 0.00 1.00 3.00
Interest
7.00 6.00 5.00 3.00 5.00 6.00 6.00 6.00 5.00 3.00 1.00 4.00
Depreciation
6.00 7.00 7.00 7.00 6.00 5.00 5.00 4.00 4.00 4.00 4.00 2.00
Profit before tax
-17.00 -27.00 -20.00 -25.00 -45.00 -28.00 -29.00 -20.00 -18.00 -16.00 -16.00 -8.00
Tax %
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Profit
-17.00 -27.00 -20.00 -25.00 -45.00 -28.00 -29.00 -20.00 -18.00 -16.00 -16.00 -8.00
EPS in Rs
-7.85 -12.50 -9.15 -11.45 -20.65 -14.45 -16.04 -12.03 -10.73 -9.67 -10.33 -6.82
Dividend Payout %
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Balance Sheet
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
22.00 22.00 22.00 22.00 22.00 20.00 18.00 17.00 14.00 14.00 13.00 10.00
Reserves
-184.00 -168.00 -141.00 -121.00 -97.00 -62.00 -43.00 -31.00 -32.00 -12.00 0.00 9.00
Borrowings
225.00 212.00 194.00 183.00 143.00 111.00 66.00 53.00 56.00 48.00 31.00 61.00
Other Liabilities
101.00 103.00 104.00 91.00 122.00 91.00 93.00 103.00 87.00 73.00 73.00 29.00
Total Liabilities
163.00 169.00 178.00 175.00 190.00 159.00 134.00 142.00 126.00 122.00 116.00 108.00
Fixed Assets
142.00 146.00 150.00 147.00 139.00 118.00 105.00 101.00 101.00 102.00 93.00 58.00
CWIP
2.00 3.00 2.00 4.00 8.00 12.00 4.00 3.00 4.00 4.00 11.00 0.00
Investments
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets
20.00 20.00 26.00 24.00 43.00 29.00 24.00 38.00 21.00 16.00 13.00 50.00
Total Assets
163.00 169.00 178.00 175.00 190.00 159.00 134.00 142.00 126.00 122.00 116.00 108.00
Cash Flows
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
-2.00 -8.00 2.00 -25.00 -17.00 -15.00 -36.00 4.00 -6.00 -11.00 -15.00 -45.00
Cash from Investing Activity
-4.00 -5.00 -8.00 -13.00 -23.00 -23.00 -10.00 -4.00 -3.00 -5.00 -4.00 -3.00
Cash from Financing Activity
6.00 13.00 6.00 37.00 40.00 38.00 29.00 17.00 9.00 16.00 13.00 54.00
Net Cash Flow
0.00 0.00 0.00 0.00 -1.00 1.00 -17.00 17.00 0.00 0.00 -6.00 6.00
Free Cash Flow
-5.00 -11.00 -5.00 -36.00 -41.00 -40.00 -45.00 -1.00 -9.00 -17.00 -23.00 -48.00
CFO/OP %
35.00 52.00 -27.00 157.00 51.00 83.00 191.00 -40.00 83.00 140.00 123.00 924.00
Ratios
Annual ยท Days / % โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
0.00 0.00 14.00 4.00 5.00 2.00 2.00 22.00 3.00 180.00 10.00 โ
Inventory Days
โ 396.00 543.00 170.00 230.00 234.00 345.00 142.00 337.00 2,162.00 14,704.00 โ
Days Payable
โ 1,192.00 1,051.00 217.00 340.00 292.00 521.00 339.00 510.00 4,360.00 32,250.00 โ
Cash Conversion Cycle
0.00 -795.00 -494.00 -44.00 -106.00 -57.00 -174.00 -175.00 -170.00 -2,018.00 -17,536.00 โ
Working Capital Days
-1,593.00 -787.00 -322.00 -232.00 -261.00 -187.00 -267.00 -315.00 -275.00 -2,132.00 -6,532.00 โ
ROCE %
-15.00 -30.00 -19.00 -29.00 -57.00 -40.00 -57.00 -36.00 -26.00 -26.00 -26.00 -8.00
Shareholding Pattern
% holding โ latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
72.74
72.74
72.74
72.74
72.74
72.74
72.74
72.74
72.74
72.74
72.74
72.74
FIIs
0.50
0.50
0.50
0.50
0.50
0.50
0.50
0.50
0.50
0.50
0.50
0.50
Public
26.76
26.77
26.76
26.76
26.76
26.75
26.76
26.76
26.75
26.75
26.77
26.76
No. of Shareholders
8,521
8,553
8,710
8,912
9,118
8,798
9,091
9,425
8,848
8,909
8,990
9,030
Corporate Actions
20 records
Back to all stocks